Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy

<div>Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis results (left) and KEGG-target networks (right). In the right panel, the arrows and squares represent pathways and potential therapeutic targets, respectively. The size of the arrows represents the ratio of the corresponding therapeutic targets, while the size of the therapeutic targets represents the ratio of the corresponding pathways. (a) Pathways enriched with targets of the compound Xueshuantong capsule. (b) Pathways enriched with targets of the Hexuemingmu tablet.</div>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 

Figure 7 | Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 